Sichuan Hebang Biotechnology Hits Day High with 9.9% Surge in Stock Price

Sichuan Hebang Biotechnology Co., Ltd. has experienced a significant surge in its stock price, gaining 9.9% on March 12, 2026. The stock reached an intraday high of CNY 3.33, marking a notable performance against the backdrop of the China Shanghai Composite, which saw a slight decline of 0.1% on the same day. Over the past week, Sichuan Hebang's stock has risen by 19.35%, and its one-month performance stands at an impressive 35.92%. Year-to-date, the stock has increased by 47.35%, significantly outperforming the China Shanghai Composite's 4.04% gain. In the past year, the stock has shown an 80% increase, while the broader index has only managed a 22.46% rise. Despite these short-term gains, the company faces challenges, including a decline in net profit and negative results over the last ten quarters. The market capitalization of Sichuan Hebang is currently CNY 21,018 million, positioning it as a large-cap player in the Chemicals & Petrochemicals industry. The stock's performance metrics indicate a complex landscape, with a high dividend yield of 1% and a debt-to-equity ratio of 0.11.